BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26753651)

  • 1. Expression and diagnosis of transient receptor potential vanilloid1 in urothelium of patients with overactive bladder.
    Zhang HY; Chu JF; Li P; Li N; Lv ZH
    J Biol Regul Homeost Agents; 2015; 29(4):875-9. PubMed ID: 26753651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the Chinese traditional prescription Suo Quan Wan on TRPV1 expression in the bladder of rats with bladder outlet obstruction.
    Lai H; Tan B; Liang Z; Yan Q; Lian Q; Wu Q; Huang P; Cao H
    BMC Complement Altern Med; 2015 Dec; 15():424. PubMed ID: 26627190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells.
    Li M; Sun Y; Simard JM; Chai TC
    Neurourol Urodyn; 2011 Apr; 30(4):606-11. PubMed ID: 21351130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity.
    Ha US; Park EY; Kim JC
    Urology; 2011 Sep; 78(3):721.e1-721.e6. PubMed ID: 21782224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
    Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
    Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.
    Liu L; Mansfield KJ; Kristiana I; Vaux KJ; Millard RJ; Burcher E
    Neurourol Urodyn; 2007; 26(3):433-8; discussion 439; discussion 451-3. PubMed ID: 17016800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells.
    Birder LA; Wolf-Johnston AS; Sun Y; Chai TC
    Acta Physiol (Oxf); 2013 Jan; 207(1):123-9. PubMed ID: 22691178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered urothelial ATP signaling in a major subset of human overactive bladder patients with pyuria.
    Contreras-Sanz A; Krska L; Balachandran AA; Curtiss NL; Khasriya R; Kelley S; Strutt M; Gill HS; Taylor KM; Mansfield KJ; Wu C; Peppiatt-Wildman CM; Malone-Lee J; Duckett J; Wildman SS
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F805-F816. PubMed ID: 27358056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of urodynamic parameters in patients with overactive bladder.
    Frenkl TL; Railkar R; Palcza J; Scott BB; Alon A; Green S; Schaefer W
    Neurourol Urodyn; 2011 Nov; 30(8):1565-9. PubMed ID: 21674594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.
    Cheng Y; Mansfield KJ; Allen W; Millard RJ; Burcher E; Moore KH
    Neurourol Urodyn; 2013 Sep; 32(7):969-73. PubMed ID: 23129360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X2 and P2X5 Receptors Mediate Bladder Hyperesthesia in ICC in Female Overactive Bladder.
    Meng M; Zheng J; Yan J; Li Q; Fang Q; Li W
    Cell Biochem Biophys; 2015 Jun; 72(2):375-83. PubMed ID: 25561285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Analysis of Urothelium of Rats with Detrusor Overactivity Induced by Bladder Outlet Obstruction.
    Park EC; Lim JS; Kim SI; Lee SY; Tak YK; Choi CW; Yun S; Park J; Lee M; Chung HK; Kim KS; Na YG; Shin JH; Kim GH
    Mol Cell Proteomics; 2018 May; 17(5):948-960. PubMed ID: 29414759
    [No Abstract]   [Full Text] [Related]  

  • 13. Gosha-jinki-gan reduces transmitter proteins and sensory receptors associated with C fiber activation induced by acetic acid in rat urinary bladder.
    Imamura T; Ishizuka O; Aizawa N; Zhong C; Ogawa T; Nakayama T; Tanabe T; Nishizawa O
    Neurourol Urodyn; 2008; 27(8):832-7. PubMed ID: 18551569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of urodynamic filling sensation at weekly interval in healthy volunteers and in women with detrusor overactivity.
    Van Meel TD; Wyndaele JJ
    Neurourol Urodyn; 2011 Nov; 30(8):1586-90. PubMed ID: 21538500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 in patients with lower urinary tract dysfunction.
    Cho KJ; Koh JS; Choi JB; Park SH; Lee WS; Kim JC
    Investig Clin Urol; 2022 May; 63(3):309-315. PubMed ID: 35437956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity.
    Liu HT; Kuo HC
    BJU Int; 2007 Nov; 100(5):1086-90. PubMed ID: 17711510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder.
    Andersson KE; Gratzke C; Hedlund P
    BJU Int; 2010 Oct; 106(8):1114-27. PubMed ID: 21156013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of urodynamic characteristics between female patients with overactive bladder and overactive bladder plus stress urinary incontinence.
    Lin LY; Yeh NH; Lin CY; Sheu BC; Lin HH
    Urology; 2004 Nov; 64(5):945-9. PubMed ID: 15533483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactive bladder is not only overactive but also hypersensitive.
    Lee SR; Kim HJ; Kim A; Kim JH
    Urology; 2010 May; 75(5):1053-9. PubMed ID: 20092879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where is TRPV1 expressed in the bladder, do we see the real channel?
    Everaerts W; SepĂșlveda MR; Gevaert T; Roskams T; Nilius B; De Ridder D
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):421-5. PubMed ID: 19153713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.